vs
Side-by-side financial comparison of First Seacoast Bancorp, Inc. (FSEA) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.
Sensus Healthcare, Inc. is the larger business by last-quarter revenue ($4.9M vs $4.0M, roughly 1.2× First Seacoast Bancorp, Inc.). First Seacoast Bancorp, Inc. runs the higher net margin — -2.4% vs -64.1%, a 61.7% gap on every dollar of revenue. On growth, First Seacoast Bancorp, Inc. posted the faster year-over-year revenue change (20.6% vs -62.2%). First Seacoast Bancorp, Inc. produced more free cash flow last quarter ($329.0K vs $-2.4M). Over the past eight quarters, First Seacoast Bancorp, Inc.'s revenue compounded faster (12.6% CAGR vs -31.9%).
Sterling Bancorp was an American regional bank holding company that owned Sterling National Bank. It merged into Webster Bank in February 2022.
Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.
FSEA vs SRTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.0M | $4.9M |
| Net Profit | $-87.0K | $-3.2M |
| Gross Margin | — | 38.4% |
| Operating Margin | -3.1% | -63.8% |
| Net Margin | -2.4% | -64.1% |
| Revenue YoY | 20.6% | -62.2% |
| Net Profit YoY | 93.8% | -304.9% |
| EPS (diluted) | $-0.04 | $-0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.0M | $4.9M | ||
| Q3 25 | $4.0M | $6.9M | ||
| Q2 25 | $3.9M | $7.3M | ||
| Q1 25 | $3.5M | $8.3M | ||
| Q4 24 | $3.4M | $13.1M | ||
| Q3 24 | $3.3M | $8.8M | ||
| Q2 24 | $5.9M | $9.2M | ||
| Q1 24 | $3.2M | $10.7M |
| Q4 25 | $-87.0K | $-3.2M | ||
| Q3 25 | $390.0K | $-943.0K | ||
| Q2 25 | $-545.0K | $-1.0M | ||
| Q1 25 | $-603.0K | $-2.6M | ||
| Q4 24 | $-1.4M | $1.5M | ||
| Q3 24 | $44.0K | $1.2M | ||
| Q2 24 | $2.0M | $1.6M | ||
| Q1 24 | $-1.2M | $2.3M |
| Q4 25 | — | 38.4% | ||
| Q3 25 | — | 39.4% | ||
| Q2 25 | — | 39.7% | ||
| Q1 25 | — | 52.2% | ||
| Q4 24 | — | 54.4% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 58.7% | ||
| Q1 24 | — | 62.5% |
| Q4 25 | -3.1% | -63.8% | ||
| Q3 25 | -5.2% | -37.3% | ||
| Q2 25 | -13.7% | -26.6% | ||
| Q1 25 | -17.9% | -31.7% | ||
| Q4 24 | -23.5% | 13.2% | ||
| Q3 24 | -17.8% | 16.9% | ||
| Q2 24 | 35.6% | 21.5% | ||
| Q1 24 | -24.8% | 27.1% |
| Q4 25 | -2.4% | -64.1% | ||
| Q3 25 | 9.8% | -13.7% | ||
| Q2 25 | -14.1% | -14.2% | ||
| Q1 25 | -17.1% | -30.8% | ||
| Q4 24 | -46.9% | 11.8% | ||
| Q3 24 | 1.3% | 13.7% | ||
| Q2 24 | 33.9% | 17.4% | ||
| Q1 24 | -36.1% | 21.3% |
| Q4 25 | $-0.04 | $-0.19 | ||
| Q3 25 | $0.08 | $-0.06 | ||
| Q2 25 | $-0.13 | $-0.06 | ||
| Q1 25 | $-0.14 | $-0.16 | ||
| Q4 24 | $-0.31 | $0.10 | ||
| Q3 24 | $0.01 | $0.07 | ||
| Q2 24 | $0.42 | $0.10 | ||
| Q1 24 | $-0.24 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $22.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $63.5M | $48.1M |
| Total Assets | $599.3M | $53.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $22.1M | ||
| Q3 25 | — | $24.5M | ||
| Q2 25 | — | $22.2M | ||
| Q1 25 | — | $19.1M | ||
| Q4 24 | — | $22.1M | ||
| Q3 24 | — | $22.6M | ||
| Q2 24 | — | $19.0M | ||
| Q1 24 | — | $14.7M |
| Q4 25 | $63.5M | $48.1M | ||
| Q3 25 | $63.2M | $51.2M | ||
| Q2 25 | $60.8M | $52.1M | ||
| Q1 25 | $61.2M | $53.0M | ||
| Q4 24 | $62.0M | $55.8M | ||
| Q3 24 | $65.8M | $54.1M | ||
| Q2 24 | $64.5M | $52.9M | ||
| Q1 24 | $64.7M | $51.2M |
| Q4 25 | $599.3M | $53.0M | ||
| Q3 25 | $609.6M | $58.3M | ||
| Q2 25 | $604.8M | $58.9M | ||
| Q1 25 | $592.6M | $60.2M | ||
| Q4 24 | $580.8M | $62.2M | ||
| Q3 24 | $601.8M | $59.9M | ||
| Q2 24 | $601.7M | $58.2M | ||
| Q1 24 | $576.5M | $57.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $449.0K | $-2.2M |
| Free Cash FlowOCF − Capex | $329.0K | $-2.4M |
| FCF MarginFCF / Revenue | 8.1% | -47.9% |
| Capex IntensityCapex / Revenue | 3.0% | 3.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.4M | $332.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $449.0K | $-2.2M | ||
| Q3 25 | $661.0K | $2.3M | ||
| Q2 25 | $-151.0K | $3.1M | ||
| Q1 25 | $573.0K | $-2.7M | ||
| Q4 24 | $-2.9M | $-827.0K | ||
| Q3 24 | $289.0K | $4.0M | ||
| Q2 24 | $-1.4M | $4.2M | ||
| Q1 24 | $-70.0K | $-8.2M |
| Q4 25 | $329.0K | $-2.4M | ||
| Q3 25 | $640.0K | $2.3M | ||
| Q2 25 | $-154.0K | $3.1M | ||
| Q1 25 | $542.0K | $-2.7M | ||
| Q4 24 | $-3.3M | $-1.1M | ||
| Q3 24 | $264.0K | $3.6M | ||
| Q2 24 | $-1.6M | $4.2M | ||
| Q1 24 | $-81.0K | $-8.4M |
| Q4 25 | 8.1% | -47.9% | ||
| Q3 25 | 16.0% | 33.3% | ||
| Q2 25 | -4.0% | 42.2% | ||
| Q1 25 | 15.4% | -32.2% | ||
| Q4 24 | -99.0% | -8.6% | ||
| Q3 24 | 7.9% | 40.9% | ||
| Q2 24 | -26.5% | 45.8% | ||
| Q1 24 | -2.5% | -79.0% |
| Q4 25 | 3.0% | 3.2% | ||
| Q3 25 | 0.5% | 0.1% | ||
| Q2 25 | 0.1% | 0.4% | ||
| Q1 25 | 0.9% | 0.1% | ||
| Q4 24 | 11.0% | 2.3% | ||
| Q3 24 | 0.7% | 3.8% | ||
| Q2 24 | 2.8% | 0.0% | ||
| Q1 24 | 0.3% | 2.2% |
| Q4 25 | — | — | ||
| Q3 25 | 1.69× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.53× | ||
| Q3 24 | 6.57× | 3.25× | ||
| Q2 24 | -0.70× | 2.62× | ||
| Q1 24 | — | -3.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FSEA
Segment breakdown not available.
SRTS
| Products | $2.8M | 57% |
| Other | $2.1M | 43% |
